|
G |
Slc14a1 |
solute carrier family 14 member 1 (Kidd blood group) |
affects transport |
ISO |
SLC14A1 protein affects the transport of formamide |
CTD |
PMID:17506977 |
|
NCBI chr18:71,565,453...71,608,807
Ensembl chr18:71,565,454...71,595,146
|
|
|
G |
Abcb1b |
ATP-binding cassette, sub-family B member 1B |
decreases expression |
EXP |
Dimethylformamide results in decreased expression of ABCB1B mRNA |
CTD |
PMID:12883083 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
increases expression multiple interactions |
ISO |
Dimethylformamide results in increased expression of ADGRE1 protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of ADGRE1 protein] |
CTD |
PMID:37995826 |
|
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
Dimethylformamide results in decreased expression of ARG1 mRNA |
CTD |
PMID:37995826 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO |
Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of BAX protein] |
CTD |
PMID:29984871 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions increases expression |
EXP ISO |
[Dimethylformamide co-treated with Carbon Tetrachloride] results in decreased expression of BCL2L1 protein Dimethylformamide results in increased expression of BCL2L1 protein Thiocarbamates analog inhibits the reaction [Dimethylformamide results in decreased expression of BCL2L1 protein] |
CTD |
PMID:20097184 PMID:29984871 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of and results in increased cleavage of CASP1 protein]; Dimethylformamide results in increased expression of and results in increased cleavage of CASP1 protein |
CTD |
PMID:37995826 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression |
EXP ISO |
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased activity of CASP3 protein Dimethylformamide results in increased expression of CASP3 protein modified form CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP3 protein modified form]; Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of CASP3 protein modified form] |
CTD |
PMID:20097184 PMID:29984871 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression |
ISO |
CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP9 protein modified form]; Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of CASP9 protein modified form] |
CTD |
PMID:29984871 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP3 protein modified form]; CAT protein inhibits the reaction [Dimethylformamide results in increased expression of CASP9 protein modified form]; CAT protein inhibits the reaction [Dimethylformamide results in increased expression of TP53 protein] |
CTD |
PMID:29984871 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases expression |
ISO |
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of CCL2 mRNA] |
CTD |
PMID:37995826 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cd163 |
CD163 molecule |
decreases expression |
ISO |
Dimethylformamide results in decreased expression of CD163 mRNA |
CTD |
PMID:37995826 |
|
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
increases phosphorylation multiple interactions |
ISO |
Dimethylformamide results in increased phosphorylation of CHUK protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased phosphorylation of CHUK protein] |
CTD |
PMID:37995826 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
affects metabolic processing increases response to substance increases abundance multiple interactions increases expression increases metabolic processing increases oxidation |
ISO EXP |
CYP2E1 protein polymorphism affects the metabolism of Dimethylformamide CYP2E1 protein results in increased susceptibility to Dimethylformamide CYP2E1 polymorphism results in increased abundance of Dimethylformamide metabolite allyl methyl disulfide inhibits the reaction [Dimethylformamide results in decreased activity of CYP2E1 protein]; CYP2E1 protein affects the reaction [Dimethylformamide results in increased activity of GPT protein]; CYP2E1 protein affects the reaction [Dimethylformamide results in increased expression of HSP90B1 protein]; Dimethylformamide results in decreased expression of and results in decreased activity of CYP2E1 protein Dimethylformamide results in increased expression of CYP2E1 protein CYP2E1 protein results in increased metabolism of Dimethylformamide CYP2E1 protein affects the metabolism of Dimethylformamide CYP2E1 protein results in increased oxidation of Dimethylformamide |
CTD |
PMID:9817075 PMID:10207612 PMID:11305777 PMID:15772367 PMID:29984871 PMID:31501917 PMID:37995826 More...
|
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
EXP |
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of DDIT3 mRNA |
CTD |
PMID:20097184 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
EXP |
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of EIF2AK3 protein modified form |
CTD |
PMID:20097184 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression multiple interactions |
ISO |
Dimethylformamide results in increased expression of GCLC protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of GCLC protein] |
CTD |
PMID:37995826 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
increases activity multiple interactions |
ISO |
Dimethylformamide results in increased activity of GOT1 protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased activity of GOT1 protein] |
CTD |
PMID:37995826 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions increases activity |
ISO |
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased activity of GPT protein]; CYP2E1 protein affects the reaction [Dimethylformamide results in increased activity of GPT protein] |
CTD |
PMID:31501917 PMID:37995826 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases expression |
EXP |
Dimethylformamide results in decreased expression of GSR mRNA |
CTD |
PMID:12883083 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
Dimethylformamide results in increased expression of H2AX protein |
CTD |
PMID:26387567 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression decreases expression |
ISO |
Alitretinoin inhibits the reaction [Dimethylformamide results in decreased expression of HMOX1 protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased expression of HMOX1 protein] allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of HMOX1 protein] Dimethylformamide results in decreased expression of HMOX1 mRNA; Dimethylformamide results in decreased expression of HMOX1 protein |
CTD |
PMID:31875996 PMID:37995826 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
multiple interactions increases expression |
EXP ISO |
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSP90B1 protein Dimethylformamide results in increased expression of HSP90B1 protein CYP2E1 protein affects the reaction [Dimethylformamide results in increased expression of HSP90B1 protein] |
CTD |
PMID:20097184 PMID:31501917 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
EXP |
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSPA5 mRNA; [Dimethylformamide co-treated with Carbon Tetrachloride] results in increased expression of HSPA5 protein |
CTD |
PMID:20097184 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Il1b |
interleukin 1 beta |
increases expression multiple interactions |
ISO |
Dimethylformamide results in increased expression of IL1B mRNA allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of and results in increased cleavage of IL1B protein]; allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of and results in increased secretion of IL1B protein]; allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of IL1B mRNA]; Dimethylformamide results in increased expression of and results in increased cleavage of IL1B protein; Dimethylformamide results in increased expression of and results in increased secretion of IL1B protein |
CTD |
PMID:37995826 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
ISO |
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of and results in increased secretion of IL6 protein]; allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of IL6 mRNA]; Dimethylformamide results in increased expression of and results in increased secretion of IL6 protein |
CTD |
PMID:37995826 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ldha |
lactate dehydrogenase A |
multiple interactions increases activity |
ISO |
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased activity of LDHA protein] |
CTD |
PMID:37995826 |
|
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Ltf |
lactotransferrin |
increases expression |
ISO |
Dimethylformamide results in increased expression of LTF mRNA |
CTD |
PMID:18063697 |
|
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO |
U 0126 inhibits the reaction [Dimethylformamide results in increased phosphorylation of MAPK1 protein] [Dimethylformamide results in increased phosphorylation of MAPK1 protein] which results in increased phosphorylation of RXRA protein; Dimethylformamide results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:31875996 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation multiple interactions |
ISO |
[Dimethylformamide results in increased phosphorylation of MAPK3 protein] which results in increased phosphorylation of RXRA protein; Dimethylformamide results in increased phosphorylation of MAPK3 protein U 0126 inhibits the reaction [Dimethylformamide results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:31875996 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mpo |
myeloperoxidase |
increases expression |
ISO |
Dimethylformamide results in increased expression of MPO mRNA |
CTD |
PMID:18063697 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
decreases expression |
ISO |
Dimethylformamide results in decreased expression of MRC1 mRNA |
CTD |
PMID:37995826 |
|
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
|
|
G |
Mrc2 |
mannose receptor, C type 2 |
decreases expression |
ISO |
Dimethylformamide results in decreased expression of MRC2 mRNA |
CTD |
PMID:37995826 |
|
NCBI chr10:90,261,986...90,323,187
Ensembl chr10:90,261,394...90,322,856
|
|
G |
Mre11 |
MRE11 homolog, double strand break repair nuclease |
increases expression |
ISO |
Dimethylformamide results in increased expression of MRE11 mRNA; Dimethylformamide results in increased expression of MRE11 protein |
CTD |
PMID:26387567 |
|
NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
increases expression |
ISO |
Dimethylformamide results in increased expression of NCF1 mRNA |
CTD |
PMID:18063697 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Nefh |
neurofilament heavy chain |
affects expression |
EXP |
Dimethylformamide affects the expression of NEFH mRNA |
CTD |
PMID:22954530 |
|
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions increases expression decreases activity |
ISO |
Alitretinoin inhibits the reaction [Dimethylformamide results in decreased activity of NFE2L2 protein]; Dimethylformamide promotes the reaction [NFE2L2 protein binds to RXRA protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased activity of NFE2L2 protein] Dimethylformamide results in increased expression of NFE2L2 protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of NFE2L2 protein] |
CTD |
PMID:31875996 PMID:37995826 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions increases phosphorylation |
ISO |
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:37995826 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
increases expression multiple interactions |
ISO |
Dimethylformamide results in increased expression of NLRP3 protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of NLRP3 protein] |
CTD |
PMID:37995826 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
ISO |
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of NOS2 mRNA]; allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of NOS2 protein] Dimethylformamide results in increased expression of NOS2 mRNA; Dimethylformamide results in increased expression of NOS2 protein |
CTD |
PMID:37995826 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions increases expression decreases expression |
ISO |
Alitretinoin inhibits the reaction [Dimethylformamide results in decreased expression of NQO1 protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased expression of NQO1 protein] allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of NQO1 protein] Dimethylformamide results in decreased expression of NQO1 mRNA; Dimethylformamide results in decreased expression of NQO1 protein |
CTD |
PMID:31875996 PMID:37995826 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
EXP |
[Dimethylformamide co-treated with Carbon Tetrachloride] results in increased cleavage of PARP1 protein |
CTD |
PMID:20097184 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions |
ISO |
Dimethylformamide results in increased expression of PTGS2 protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of PTGS2 protein] |
CTD |
PMID:37995826 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pycard |
PYD and CARD domain containing |
increases expression multiple interactions |
ISO |
Dimethylformamide results in increased expression of PYCARD protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of PYCARD protein] |
CTD |
PMID:37995826 |
|
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Rad50 |
RAD50 double strand break repair protein |
increases expression |
ISO |
Dimethylformamide results in increased expression of RAD50 mRNA; Dimethylformamide results in increased expression of RAD50 protein |
CTD |
PMID:26387567 |
|
NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
|
|
G |
Rad51 |
RAD51 recombinase |
increases expression |
ISO |
Dimethylformamide results in increased expression of RAD51 mRNA; Dimethylformamide results in increased expression of RAD51 protein |
CTD |
PMID:26387567 |
|
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases phosphorylation |
ISO |
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of and results in increased phosphorylation of RELA protein]; allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased phosphorylation of RELA protein]; Dimethylformamide results in increased expression of and results in increased phosphorylation of RELA protein |
CTD |
PMID:37995826 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rxra |
retinoid X receptor alpha |
decreases degradation multiple interactions increases phosphorylation |
ISO |
Dimethylformamide results in decreased degradation of RXRA protein Alitretinoin inhibits the reaction [Dimethylformamide results in decreased degradation of RXRA protein]; Dimethylformamide promotes the reaction [NFE2L2 protein binds to RXRA protein]; U 0126 inhibits the reaction [Dimethylformamide results in decreased degradation of RXRA protein] [Dimethylformamide results in increased phosphorylation of MAPK1 protein] which results in increased phosphorylation of RXRA protein; [Dimethylformamide results in increased phosphorylation of MAPK3 protein] which results in increased phosphorylation of RXRA protein |
CTD |
PMID:31875996 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression multiple interactions |
ISO |
Dimethylformamide results in increased expression of SOD1 mRNA; Dimethylformamide results in increased expression of SOD1 protein allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of SOD1 protein] |
CTD |
PMID:35238128 PMID:37995826 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
multiple interactions |
ISO |
Dimethylformamide inhibits the reaction [SULT1A1 protein results in increased sulfation of 1-hydroxypyrene]; Dimethylformamide inhibits the reaction [SULT1A1 protein results in increased sulfation of 4-nitrophenol] |
CTD |
PMID:14570759 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Sult2a1 |
sulfotransferase family 2A member 1 |
multiple interactions |
ISO |
Dimethylformamide inhibits the reaction [SULT2A1 protein results in increased sulfation of 1-hydroxypyrene] |
CTD |
PMID:14570759 |
|
NCBI chr 1:75,451,178...75,508,113
Ensembl chr 1:74,911,100...75,508,134
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression increases secretion |
ISO |
allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of and results in increased secretion of TNF protein]; allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of TNF mRNA]; allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased secretion of TNF protein]; Dimethylformamide results in increased expression of and results in increased secretion of TNF protein |
CTD |
PMID:37995826 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
increases expression |
ISO |
Dimethylformamide results in increased expression of TNFSF10 mRNA; Dimethylformamide results in increased expression of TNFSF10 protein |
CTD |
PMID:18063697 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression |
ISO |
CAT protein inhibits the reaction [Dimethylformamide results in increased expression of TP53 protein]; Thiocarbamates analog inhibits the reaction [Dimethylformamide results in increased expression of TP53 protein] Dimethylformamide results in increased expression of TP53 protein modified form |
CTD |
PMID:29984871 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trim28 |
tripartite motif-containing 28 |
decreases expression |
ISO |
Dimethylformamide results in decreased expression of TRIM28 mRNA |
CTD |
PMID:35238128 |
|
NCBI chr 1:73,652,441...73,659,388
Ensembl chr 1:73,652,709...73,659,380
|
|
G |
Xrcc2 |
X-ray repair cross complementing 2 |
increases expression affects expression |
ISO |
Dimethylformamide results in increased expression of XRCC2 protein Dimethylformamide affects the expression of XRCC2 mRNA |
CTD |
PMID:26387567 |
|
NCBI chr 4:9,423,873...9,502,980
Ensembl chr 4:9,423,898...9,442,482
|
|
G |
Xrcc3 |
X-ray repair cross complementing 3 |
increases expression |
ISO |
Dimethylformamide results in increased expression of XRCC3 mRNA; Dimethylformamide results in increased expression of XRCC3 protein |
CTD |
PMID:26387567 |
|
NCBI chr 6:130,863,405...130,873,765
Ensembl chr 6:130,863,959...130,872,444
|
|
G |
Zp2 |
zona pellucida glycoprotein 2 |
increases expression |
ISO |
Dimethylformamide results in increased expression of ZP2 mRNA |
CTD |
PMID:35238128 |
|
NCBI chr 1:174,513,507...174,525,288
Ensembl chr 1:174,513,511...174,525,288
|
|
|
G |
Adamts7 |
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
affects expression |
ISO |
methylformamide affects the expression of ADAMTS7 mRNA; methylformamide analog affects the expression of ADAMTS7 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 8:90,704,727...90,744,333
Ensembl chr 8:90,704,727...90,744,328
|
|
G |
Ampd2 |
adenosine monophosphate deaminase 2 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of AMPD2 mRNA; methylformamide results in decreased expression of AMPD2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 2:195,707,609...195,720,454
Ensembl chr 2:195,707,610...195,720,271
|
|
G |
Angptl4 |
angiopoietin-like 4 |
increases expression |
ISO |
methylformamide analog results in increased expression of ANGPTL4 mRNA; methylformamide results in increased expression of ANGPTL4 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Ankrd10 |
ankyrin repeat domain 10 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of ANKRD10 mRNA; methylformamide results in decreased expression of ANKRD10 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr16:77,866,489...77,889,745
Ensembl chr16:77,864,261...77,889,745
|
|
G |
Anxa6 |
annexin A6 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of ANXA6 mRNA; methylformamide results in decreased expression of ANXA6 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
|
|
G |
Aox1 |
aldehyde oxidase 1 |
increases expression |
ISO |
methylformamide analog results in increased expression of AOX1 mRNA; methylformamide results in increased expression of AOX1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
|
|
G |
Arl4a |
ADP-ribosylation factor like GTPase 4A |
affects expression |
ISO |
methylformamide affects the expression of ARL4A mRNA; methylformamide analog affects the expression of ARL4A mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 6:57,079,496...57,084,156
Ensembl chr 6:57,078,812...57,085,066
|
|
G |
B3galnt1 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
decreases expression |
ISO |
methylformamide analog results in decreased expression of B3GALNT1 mRNA; methylformamide results in decreased expression of B3GALNT1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 2:153,847,297...153,877,371
Ensembl chr 2:153,846,474...153,877,332
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of BIRC2 mRNA; methylformamide results in decreased expression of BIRC2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Brd2 |
bromodomain containing 2 |
increases expression |
ISO |
methylformamide analog results in increased expression of BRD2 mRNA; methylformamide results in increased expression of BRD2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr20:4,727,078...4,735,389
Ensembl chr20:4,728,151...4,735,388
|
|
G |
Cacybp |
calcyclin binding protein |
increases expression |
ISO |
methylformamide analog results in increased expression of CACYBP mRNA; methylformamide results in increased expression of CACYBP mRNA |
CTD |
PMID:17040096 |
|
NCBI chr13:72,437,485...72,447,810
Ensembl chr13:72,437,490...72,450,177
|
|
G |
Cavin2 |
caveolae associated protein 2 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of CAVIN2 mRNA; methylformamide results in decreased expression of CAVIN2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 9:50,302,079...50,314,096
Ensembl chr 9:50,301,206...50,314,147
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression |
ISO |
methylformamide analog results in increased expression of CCL3 mRNA; methylformamide results in increased expression of CCL3 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccn2 |
cellular communication network factor 2 |
increases expression |
ISO |
methylformamide analog results in increased expression of CCN2 mRNA; methylformamide results in increased expression of CCN2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of CCND1 mRNA; methylformamide results in decreased expression of CCND1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of CCND2 mRNA; methylformamide results in decreased expression of CCND2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Cdc45 |
cell division cycle 45 |
increases expression |
ISO |
methylformamide analog results in increased expression of CDC45 mRNA; methylformamide results in increased expression of CDC45 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
|
|
G |
Cish |
cytokine inducible SH2-containing protein |
decreases expression |
ISO |
methylformamide analog results in decreased expression of CISH mRNA; methylformamide results in decreased expression of CISH mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
|
|
G |
Clstn2 |
calsyntenin 2 |
increases expression |
ISO |
methylformamide analog results in increased expression of CLSTN2 mRNA; methylformamide results in increased expression of CLSTN2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 8:98,020,406...98,637,232
Ensembl chr 8:98,021,666...98,637,731
|
|
G |
Csnk1d |
casein kinase 1, delta |
affects expression |
ISO |
methylformamide affects the expression of CSNK1D mRNA; methylformamide analog affects the expression of CSNK1D mRNA |
CTD |
PMID:17040096 |
|
NCBI chr10:106,221,992...106,256,620
Ensembl chr10:106,221,992...106,256,614
|
|
G |
Cxadr |
CXADR, Ig-like cell adhesion molecule |
affects expression |
ISO |
methylformamide affects the expression of CXADR mRNA; methylformamide analog affects the expression of CXADR mRNA |
CTD |
PMID:17040096 |
|
NCBI chr11:16,982,864...17,030,078
Ensembl chr11:16,982,860...17,030,046
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases metabolic processing multiple interactions |
ISO EXP |
CYP2E1 protein results in increased metabolism of methylformamide 4-nitrophenol inhibits the reaction [CYP2E1 protein results in increased metabolism of methylformamide]; Dimethyl Sulfoxide inhibits the reaction [CYP2E1 protein results in increased metabolism of methylformamide]; Ditiocarb inhibits the reaction [CYP2E1 protein results in increased metabolism of methylformamide]; Fomepizole promotes the reaction [CYP2E1 protein results in increased metabolism of methylformamide] |
CTD |
PMID:1538706 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Dnaja1 |
DnaJ heat shock protein family (Hsp40) member A1 |
increases expression |
ISO |
methylformamide analog results in increased expression of DNAJA1 mRNA; methylformamide results in increased expression of DNAJA1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
affects expression |
ISO |
methylformamide affects the expression of DNMT3A mRNA; methylformamide analog affects the expression of DNMT3A mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dusp10 |
dual specificity phosphatase 10 |
affects expression |
ISO |
methylformamide affects the expression of DUSP10 mRNA; methylformamide analog affects the expression of DUSP10 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
increases expression |
ISO |
methylformamide analog results in increased expression of DUSP6 mRNA; methylformamide results in increased expression of DUSP6 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dusp7 |
dual specificity phosphatase 7 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of DUSP7 mRNA; methylformamide results in decreased expression of DUSP7 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 8:107,009,369...107,016,404
Ensembl chr 8:107,008,528...107,016,404
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression |
ISO |
methylformamide analog results in decreased expression of EGFR mRNA; methylformamide results in decreased expression of EGFR mRNA |
CTD |
PMID:17040096 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
affects expression |
ISO |
methylformamide affects the expression of ENTPD5 mRNA; methylformamide analog affects the expression of ENTPD5 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 6:104,019,095...104,055,311
Ensembl chr 6:104,019,185...104,055,530
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
increases expression |
ISO |
methylformamide analog results in increased expression of FGF21 mRNA; methylformamide results in increased expression of FGF21 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Fn1 |
fibronectin 1 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of FN1 mRNA; methylformamide results in decreased expression of FN1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
methylformamide analog results in increased expression of FOS mRNA; methylformamide results in increased expression of FOS mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gabarapl1 |
GABA type A receptor associated protein like 1 |
increases expression |
ISO |
methylformamide analog results in increased expression of GABARAPL1 mRNA; methylformamide results in increased expression of GABARAPL1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 4:162,980,309...162,989,452
Ensembl chr 4:162,980,249...162,989,450
|
|
G |
Gas2 |
growth arrest-specific 2 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of GAS2 mRNA; methylformamide results in decreased expression of GAS2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
affects expression |
ISO |
methylformamide affects the expression of GCLC mRNA; methylformamide analog affects the expression of GCLC mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
methylformamide analog results in increased expression of GDF15 mRNA; methylformamide results in increased expression of GDF15 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdf9 |
growth differentiation factor 9 |
increases expression |
ISO |
methylformamide analog results in increased expression of GDF9 mRNA; methylformamide results in increased expression of GDF9 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr10:37,589,200...37,599,970
Ensembl chr10:37,595,679...37,599,672
|
|
G |
Grpel2 |
GrpE-like 2, mitochondrial |
increases expression |
ISO |
methylformamide analog results in increased expression of GRPEL2 mRNA; methylformamide results in increased expression of GRPEL2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr18:55,167,831...55,180,073
Ensembl chr18:55,168,209...55,180,180
|
|
G |
Gsdme |
gasdermin E |
increases expression |
ISO |
methylformamide analog results in increased expression of GSDME mRNA; methylformamide results in increased expression of GSDME mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 4:79,258,799...79,321,129
Ensembl chr 4:79,257,804...79,320,806
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
affects expression |
ISO |
methylformamide affects the expression of GSTA2 mRNA; methylformamide analog affects the expression of GSTA2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gtf2ird1 |
GTF2I repeat domain containing 1 |
affects expression |
ISO |
methylformamide affects the expression of GTF2IRD1 mRNA; methylformamide analog affects the expression of GTF2IRD1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr12:22,254,113...22,361,052
Ensembl chr12:22,254,221...22,361,040
|
|
G |
Gtpbp2 |
GTP binding protein 2 |
affects expression |
ISO |
methylformamide affects the expression of GTPBP2 mRNA; methylformamide analog affects the expression of GTPBP2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 9:14,813,964...14,823,419
Ensembl chr 9:14,813,964...14,823,241
|
|
G |
Habp2 |
hyaluronan binding protein 2 |
increases expression |
ISO |
methylformamide analog results in increased expression of HABP2 mRNA; methylformamide results in increased expression of HABP2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 1:255,315,870...255,350,161
Ensembl chr 1:255,315,915...255,350,160
|
|
G |
Hbp1 |
HMG-box transcription factor 1 |
increases expression |
ISO |
methylformamide analog results in increased expression of HBP1 mRNA; methylformamide results in increased expression of HBP1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
affects expression |
ISO |
methylformamide affects the expression of HMGCR mRNA; methylformamide analog affects the expression of HMGCR mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmox1 |
heme oxygenase 1 |
affects expression |
ISO |
methylformamide affects the expression of HMOX1 mRNA; methylformamide analog affects the expression of HMOX1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of HNRNPA2B1 mRNA; methylformamide results in decreased expression of HNRNPA2B1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
affects expression |
ISO |
methylformamide affects the expression of HSPA1B mRNA; methylformamide analog affects the expression of HSPA1B mRNA |
CTD |
PMID:17040096 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
increases expression |
ISO |
methylformamide analog results in increased expression of HSPA8 mRNA; methylformamide results in increased expression of HSPA8 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
affects expression |
ISO |
methylformamide affects the expression of HSPB1 mRNA; methylformamide analog affects the expression of HSPB1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Hspb8 |
heat shock protein family B (small) member 8 |
affects expression |
ISO |
methylformamide affects the expression of HSPB8 mRNA; methylformamide analog affects the expression of HSPB8 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:40,176,532...40,191,185
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
increases expression |
ISO |
methylformamide analog results in increased expression of HSPD1 mRNA; methylformamide results in increased expression of HSPD1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Hsph1 |
heat shock protein family H (Hsp110) member 1 |
increases expression |
ISO |
methylformamide analog results in increased expression of HSPH1 mRNA; methylformamide results in increased expression of HSPH1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
affects expression |
ISO |
methylformamide affects the expression of IKBKG mRNA; methylformamide analog affects the expression of IKBKG mRNA |
CTD |
PMID:17040096 |
|
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
|
|
G |
Il15ra |
interleukin 15 receptor subunit alpha |
decreases expression |
ISO |
methylformamide analog results in decreased expression of IL15RA mRNA; methylformamide results in decreased expression of IL15RA mRNA |
CTD |
PMID:17040096 |
|
NCBI chr17:66,802,300...66,831,973
Ensembl chr17:66,802,334...66,832,278
|
|
G |
Il1rap |
interleukin 1 receptor accessory protein |
decreases expression |
ISO |
methylformamide analog results in decreased expression of IL1RAP mRNA; methylformamide results in decreased expression of IL1RAP mRNA |
CTD |
PMID:17040096 |
|
NCBI chr11:74,062,999...74,199,530
Ensembl chr11:74,070,304...74,199,530
|
|
G |
Inpp1 |
inositol polyphosphate-1-phosphatase |
decreases expression |
ISO |
methylformamide analog results in decreased expression of INPP1 mRNA; methylformamide results in decreased expression of INPP1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 9:48,688,037...48,717,793
Ensembl chr 9:48,669,901...48,717,793
|
|
G |
Kcnk5 |
potassium two pore domain channel subfamily K member 5 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of KCNK5 mRNA; methylformamide results in decreased expression of KCNK5 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr15:4,122,442...4,164,718
Ensembl chr15:4,122,442...4,164,718
|
|
G |
Kdm2b |
lysine demethylase 2B |
decreases expression |
ISO |
methylformamide analog results in decreased expression of KDM2B mRNA; methylformamide results in decreased expression of KDM2B mRNA |
CTD |
PMID:17040096 |
|
NCBI chr12:33,566,530...33,701,366
Ensembl chr12:33,574,657...33,701,355
|
|
G |
Klf6 |
KLF transcription factor 6 |
affects expression |
ISO |
methylformamide affects the expression of KLF6 mRNA; methylformamide analog affects the expression of KLF6 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
|
|
G |
Lgals7 |
galectin 7 |
affects expression |
ISO |
methylformamide affects the expression of LGALS7 mRNA; methylformamide analog affects the expression of LGALS7 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 1:84,148,612...84,152,016
Ensembl chr 1:84,150,252...84,152,015
|
|
G |
Lipg |
lipase G, endothelial type |
decreases expression |
ISO |
methylformamide analog results in decreased expression of LIPG mRNA; methylformamide results in decreased expression of LIPG mRNA |
CTD |
PMID:17040096 |
|
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
|
|
G |
Lpin2 |
lipin 2 |
increases expression |
ISO |
methylformamide analog results in increased expression of LPIN2 mRNA; methylformamide results in increased expression of LPIN2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 9:111,083,378...111,158,193
Ensembl chr 9:111,083,745...111,158,193
|
|
G |
Ly96 |
lymphocyte antigen 96 |
affects expression |
ISO |
methylformamide affects the expression of LY96 mRNA; methylformamide analog affects the expression of LY96 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
|
|
G |
Mafk |
MAF bZIP transcription factor K |
affects expression |
ISO |
methylformamide affects the expression of MAFK mRNA; methylformamide analog affects the expression of MAFK mRNA |
CTD |
PMID:17040096 |
|
NCBI chr12:14,834,628...14,856,414
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
|
|
G |
Nde1 |
nudE neurodevelopment protein 1 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of NDE1 mRNA; methylformamide results in decreased expression of NDE1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr10:839,788...883,946
Ensembl chr10:839,788...883,869
|
|
G |
Noct |
nocturnin |
decreases expression |
ISO |
methylformamide analog results in decreased expression of NOCT mRNA; methylformamide results in decreased expression of NOCT mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 2:135,271,189...135,291,407
Ensembl chr 2:135,271,189...135,291,400
|
|
G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
increases expression |
ISO |
methylformamide analog results in increased expression of NR1D2 mRNA; methylformamide results in increased expression of NR1D2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
affects expression |
ISO |
methylformamide affects the expression of PGD mRNA; methylformamide analog affects the expression of PGD mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Plk3 |
polo-like kinase 3 |
increases expression |
ISO |
methylformamide analog results in increased expression of PLK3 mRNA; methylformamide results in increased expression of PLK3 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
|
|
G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
affects expression |
ISO |
methylformamide affects the expression of PNRC1 mRNA; methylformamide analog affects the expression of PNRC1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 5:47,647,070...47,657,832
Ensembl chr 5:47,647,071...47,650,161
|
|
G |
Ppp1r10 |
protein phosphatase 1, regulatory subunit 10 |
increases expression |
ISO |
methylformamide analog results in increased expression of PPP1R10 mRNA; methylformamide results in increased expression of PPP1R10 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr20:2,822,995...2,838,125
Ensembl chr20:2,822,995...2,837,611
|
|
G |
Rbpms |
RNA binding protein, mRNA processing factor |
affects expression |
ISO |
methylformamide affects the expression of RBPMS mRNA; methylformamide analog affects the expression of RBPMS mRNA |
CTD |
PMID:17040096 |
|
NCBI chr16:58,239,370...58,395,424
Ensembl chr16:58,239,474...58,395,426
|
|
G |
Rcan1 |
regulator of calcineurin 1 |
affects expression |
ISO |
methylformamide affects the expression of RCAN1 mRNA; methylformamide analog affects the expression of RCAN1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr11:31,622,208...31,702,150
Ensembl chr11:31,622,210...31,702,045
|
|
G |
Rtp3 |
receptor (chemosensory) transporter protein 3 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of RTP3 mRNA; methylformamide results in decreased expression of RTP3 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 8:110,970,154...110,975,000
Ensembl chr 8:110,970,160...110,974,699
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
increases expression |
ISO |
methylformamide analog results in increased expression of SGK1 mRNA; methylformamide results in increased expression of SGK1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
increases expression |
ISO |
methylformamide analog results in increased expression of SGK2 mRNA; methylformamide results in increased expression of SGK2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
|
|
G |
Sirt1 |
sirtuin 1 |
increases expression |
ISO |
methylformamide analog results in increased expression of SIRT1 mRNA; methylformamide results in increased expression of SIRT1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc14a1 |
solute carrier family 14 member 1 (Kidd blood group) |
multiple interactions affects transport |
ISO |
methylformamide inhibits the reaction [SLC14A1 protein affects the transport of Urea] SLC14A1 protein affects the transport of methylformamide |
CTD |
PMID:17506977 |
|
NCBI chr18:71,565,453...71,608,807
Ensembl chr18:71,565,454...71,595,146
|
|
G |
Slc25a19 |
solute carrier family 25 member 19 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of SLC25A19 mRNA; methylformamide results in decreased expression of SLC25A19 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr10:100,853,554...100,867,517
Ensembl chr10:100,847,168...100,867,447
|
|
G |
Slc38a2 |
solute carrier family 38, member 2 |
increases expression |
ISO |
methylformamide analog results in increased expression of SLC38A2 mRNA; methylformamide results in increased expression of SLC38A2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
|
|
G |
Slc39a8 |
solute carrier family 39 member 8 |
increases expression |
ISO |
methylformamide analog results in increased expression of SLC39A8 mRNA; methylformamide results in increased expression of SLC39A8 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 2:224,171,787...224,319,326
Ensembl chr 2:224,256,654...224,319,129
|
|
G |
Sqstm1 |
sequestosome 1 |
affects expression |
ISO |
methylformamide affects the expression of SQSTM1 mRNA; methylformamide analog affects the expression of SQSTM1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of SREBF1 mRNA; methylformamide results in decreased expression of SREBF1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srpk2 |
SRSF protein kinase 2 |
increases expression |
ISO |
methylformamide analog results in increased expression of SRPK2 mRNA; methylformamide results in increased expression of SRPK2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 4:11,464,684...11,655,993
Ensembl chr 4:11,464,674...11,655,990
|
|
G |
Srxn1 |
sulfiredoxin 1 |
affects expression |
ISO |
methylformamide affects the expression of SRXN1 mRNA; methylformamide analog affects the expression of SRXN1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Thrsp |
thyroid hormone responsive |
decreases expression |
ISO |
methylformamide analog results in decreased expression of THRSP mRNA; methylformamide results in decreased expression of THRSP mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
affects expression |
ISO |
methylformamide affects the expression of TNFAIP6 mRNA; methylformamide analog affects the expression of TNFAIP6 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
|
|
G |
Tob1 |
transducer of ErbB-2.1 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of TOB1 mRNA; methylformamide results in decreased expression of TOB1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr10:79,163,093...79,165,131
Ensembl chr10:79,160,154...79,165,215
|
|
G |
Topors |
TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase |
increases expression |
ISO |
methylformamide analog results in increased expression of TOPORS mRNA; methylformamide results in increased expression of TOPORS mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 5:55,388,033...55,399,937
Ensembl chr 5:55,387,632...55,399,937
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
affects expression |
ISO |
methylformamide affects the expression of TRIB3 mRNA; methylformamide analog affects the expression of TRIB3 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
affects expression |
ISO |
methylformamide affects the expression of TXNRD1 mRNA; methylformamide analog affects the expression of TXNRD1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Ubap1 |
ubiquitin-associated protein 1 |
affects expression |
ISO |
methylformamide affects the expression of UBAP1 mRNA; methylformamide analog affects the expression of UBAP1 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 5:56,520,722...56,561,153
Ensembl chr 5:56,520,743...56,561,152
|
|
G |
Ugdh |
UDP-glucose 6-dehydrogenase |
affects expression |
ISO |
methylformamide affects the expression of UGDH mRNA; methylformamide analog affects the expression of UGDH mRNA |
CTD |
PMID:17040096 |
|
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
|
|
G |
Ugp2 |
UDP-glucose pyrophosphorylase 2 |
increases expression |
ISO |
methylformamide analog results in increased expression of UGP2 mRNA; methylformamide results in increased expression of UGP2 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr14:95,456,330...95,497,483
Ensembl chr14:95,456,330...95,496,830
|
|
G |
Usp9x |
ubiquitin specific peptidase 9, X-linked |
increases expression |
ISO |
methylformamide analog results in increased expression of USP9X mRNA; methylformamide results in increased expression of USP9X mRNA |
CTD |
PMID:17040096 |
|
NCBI chr X:9,588,825...9,726,993
Ensembl chr X:9,588,825...9,696,711
|
|
G |
Vegfd |
vascular endothelial growth factor D |
increases expression |
ISO |
methylformamide analog results in increased expression of VEGFD mRNA; methylformamide results in increased expression of VEGFD mRNA |
CTD |
PMID:17040096 |
|
NCBI chr X:30,073,122...30,108,413
Ensembl chr X:30,074,163...30,108,295
|
|
G |
Zfp467 |
zinc finger protein 467 |
decreases expression |
ISO |
methylformamide analog results in decreased expression of ZFP467 mRNA; methylformamide results in decreased expression of ZFP467 mRNA |
CTD |
PMID:17040096 |
|
NCBI chr 4:77,385,752...77,394,709
Ensembl chr 4:77,385,758...77,392,229
|
|
G |
Zfx |
zinc finger protein X-linked |
increases expression |
ISO |
methylformamide analog results in increased expression of ZFX mRNA; methylformamide results in increased expression of ZFX mRNA |
CTD |
PMID:17040096 |
|
NCBI chr X:58,804,690...58,853,155
Ensembl chr X:58,804,691...58,853,265
|
|
G |
Zwint |
ZW10 interacting kinetochore protein |
affects expression |
ISO |
methylformamide affects the expression of ZWINT mRNA; methylformamide analog affects the expression of ZWINT mRNA |
CTD |
PMID:17040096 |
|
NCBI chr20:15,938,157...15,953,997
Ensembl chr20:15,938,157...15,953,957
|
|